iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes: a Pilot Randomized, Controlled Trial
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:
• All patients \>/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks.
• Non-anomalous singletons
• Ability to provide informed consent
Locations
United States
Texas
The University of Texas Health Science Center at Houston
RECRUITING
Houston
Contact Information
Primary
Joycelyn Corthwaite, RD
joycelyn.a.cornthwaite@uth.tmc.edu
832-325-7205
Backup
Clara Ward, MD
clara.ward@uth.tmc.edu
713-500-6412
Time Frame
Start Date: 2019-11-12
Estimated Completion Date: 2022-11-01
Participants
Target number of participants: 200
Treatments
Experimental: iGlucose Smart Meter
Placebo_comparator: Rx glucose meter
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center, Houston
Collaborators: Smart Meter Corporation